Background Two-stage reimplantation has consistently yielded high rates of success for patients with chronic prosthetic joint infection, although results more than 5 years after reimplantation are not commonly reported. Numerous factors may contribute to the risk of reinfection, although these factors-as well as the at-risk period after reimplantation-are not well characterized. Questions/purposes (1) What is the risk of reinfection after reimplantation for prosthetic joint infection at a minimum of 5 years? (2) Is the bacteriology of the index infection associated with late reinfection? (3) Is the presence of bacteria at the time of reimplantation associated with late reinfection? Methods Between 1995 and 2010, we performed 97 two-stage revisions in 93 patients for prosthetic joint infection of the hip or knee, and all are included in this retrospective study. During that time, the indications for this procedure generally were (1) infections occurring more than 3 months after the index arthroplasty; and (2) more acute infections associated with prosthetic loosening or resistant organisms. One patient (1%) was lost to followup; all others have a minimum of 5 years of followup (mean, 11 years; range, 5-20 years) and all living patients have been seen within the last 2 years. Patients were considered free from infection if they did not have pain at rest or constitutional symptoms such as fever, chills, or malaise. The patients' bacteriology and resistance patterns of these organisms were observed with respect to recurrence of infection. Odds ratios and Fisher's exact test were performed to analyze the data. The incidence of reinfection was determined using cumulative incidence methods that considered death as a competing event.
reimplantation associated with late reinfection? Methods Between 1995 and 2010, we performed 97 two-stage revisions in 93 patients for prosthetic joint infection of the hip or knee, and all are included in this retrospective study. During that time, the indications for this procedure generally were (1) infections occurring more than 3 months after the index arthroplasty; and (2) more acute infections associated with prosthetic loosening or resistant organisms. One patient (1%) was lost to followup; all others have a minimum of 5 years of followup (mean, 11 years; range, 5-20 years) and all living patients have been seen within the last 2 years. Patients were considered free from infection if they did not have pain at rest or constitutional symptoms such as fever, chills, or malaise. The patients' bacteriology and resistance patterns of these organisms were observed with respect to recurrence of infection. Odds ratios and Fisher's exact test were performed to analyze the data. The incidence of reinfection was determined using cumulative incidence methods that considered death as a competing event.
Results Reinfection occurred in 12 of the 97 joints resulting in implant revision. The estimated 10-year cumulative incidence of infection was 14% (95% confidence interval [CI] , 7%-23%) and incidence of infection from the same organism was 5% (95% CI, 1%-11%). Five occurred early or within 2 years and three were resistant pathogens (methicillin-resistant Staphylococcus aureus, methicillinresistant Staphylococcus epidermidis, or vancomycin-resistant Enterococcus). Seven late hematogenous infections occurred and all were > 4 years after reimplantation and involved nonresistant organisms. Three of the five (60%) early infections were caused by resistant bacteria, whereas all seven late infections were caused by different organisms or a combination of different organisms than were isolated in the original infection. The early reinfections were more often caused by resistant organisms, whereas late infections involved different organisms than were isolated in the original infection and none involved resistant organisms. With the numbers available, we found no difference between patients in whom bacteria were detected at the time of reimplantation and those in whom cultures were negative in terms of the risk of reinfection 5 years after reimplantation (18 Conclusions In our study, resistant organisms were more often associated with early reinfection, whereas late failures were more commonly associated with new pathogens. We believe the most important finding in our study is that substantial risk of late infection remains even among patients who seemed free from infection 2 years after reimplantation for prosthetic joint infections of the hip or knee. This highlights the importance of educating our patients about the ongoing risk of prosthetic joint infection.
Level of Evidence: Level III, therapeutic study.
Introduction
T wo-stage reimplantation of the prosthetic hip or knee has been a widely accepted and successful surgery for prosthetic joint infection (PJI). The success as measured by absence of reinfection has ranged from as low as 66% to as high as 100% [3, 5, 8, 13, 16, 17, 19, 22, 23, 28, 30, 32, 33, 35, 37, 38] . Although reimplantation is generally successful, the varying success is thought to be dependent on numerous factors including the health of the host, the type of bacteria and its resistance or susceptibility to antibiotics, the presence or absence of bacteria identified at the time of reimplantation, and the surgeon's experience managing patients with PJI [7, 21, 23-25, 28, 30-32, 39] .
As we have continued to follow our patients from an earlier study [36] , it has become evident that despite good short-term results, longterm success is not guaranteed. Although with the numbers available in that study we found no difference between sensitive and resistant organisms in terms of the likelihood that infection would persist or recur, others have suggested that this factor may indeed be very important [18, 36] . It therefore seemed important to follow the original group to see whether this factor is associated with recurrent or persistent infection.
The lack of longer followup results of patients treated with two-stage reimplantation limits our ability to educate our patients about their expected outcome and it is this dilemma that encouraged us to embark on this investigation. We asked the following questions: (1) What is the risk of reinfection after reimplantation for PJI at a minimum of 5 years? (2) Is the bacteriology of the index infection associated with late reinfection? (3) Is the presence of bacteria identified at the time of reimplantation associated with late reinfection?
Patients and Methods
One hundred thirty-six patients with 140 PJIs were identified in our medical records as patients who had been evaluated and treated at our institution between 1995 and 2010. Approval was obtained through the institutional review board for the purpose of chart review and patient participation in the study in conformity with standard ethical principles of human subject research. During that time, our general indications were informed by the work of Tsukayama et al. [34] . Acute infections (within 3 months) were managed according to the infecting organism. Infections involving sensitive bacteria were treated with surgical incision, débridement, and component retention. Those involving resistant bacteria (methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis, or vancomycin-resistant Enterococcus) underwent two-stage reimplantation.
Patients with acute hematogenous infections with well-fixed components, symptoms of short duration, and sensitive pathogens were treated with surgical incision and débridement. Patients with acute hematogenous infection with implants that had progressive radiolucencies and were loose or harbored resistant organisms underwent two-stage reimplantation. The late (presentation greater than 3 months after primary surgery) chronic infections were treated with a twostage procedure.
Based on those indications, 126 (90%) of the 140 joints were either salvaged or reimplanted and 14 had resection arthroplasty. Twenty-eight were treated with incision and débridement and component retention, one with one-stage reimplantation, and 14 with resection arthroplasty as a definitive procedure, one of which ultimately underwent above-knee amputation to control the infection. Those joints not salvaged or reimplanted included six patients who refused further surgery and found their situation acceptable, three who were medically too infirm for reimplantation, two who died months after their resection, and two who returned to their referring surgeon for definitive treatment. The remaining 97 joints (45 hips, 52 knees) were treated with twostage reimplantation for their PJI at our institution. This group included 34 women and 59 men with a median age of 73 years (range, 38-89 years) at the time of reimplantation. The first stage of the two-stage reimplantation included débridement of the infected and necrotic tissue, removal of the prosthesis and all foreign material, and placement of an antibiotic-laden spacer. The antibiotics selected were vancomycin and tobramycin mixed by hand in Simplex™ cement (Stryker, Kalamazoo, MI, USA). Total dose was typically four vials of vancomycin (1 g/ vial) in 1.5 to two batches of cement and four vials of tobramycin (1.2 g/ vial) for each component (knee: femur and tibia, hip: acetabulum and femur), a maximum dose of 8 g vancomycin and 9.6 g tobramycin. The dose increased slightly after information became available about the general safety of higher doses [29] . Hip spacers were dynamic, whereas knee spacers were dynamic except in the setting of severe loss of bone stock or when management of the soft tissues necessitated immobilization with a static spacer. Patients then received 6 weeks of intravenous antibiotics followed by an interval of 6 weeks or more without the antibiotic. The erythrocyte sedimentation rate and C-reactive protein laboratory values were obtained before reimplantation and, in all of the patients, they were either trending downward or had normalized. Aspirations were not performed before reimplantation. Tissue and fluid specimens (normally four) were obtained from the surgical site and sent for culture. Cultures were kept for 2 weeks until final results were obtained or for up to 3 weeks if a slowgrowing pathogen had been previously identified (Propionibacterium acnes). The reimplantation was performed approximately 3 months from the time of resection arthroplasty. The reimplanted hips were all cementless designs, whereas knees were cemented. All patients were treated with intravenous or oral antibiotics until final cultures were obtained. Patients with negative cultures did not receive antibiotics beyond the point at which final cultures were returned. Those patients with positive cultures received 6 weeks of intravenous antibiotics and were not considered for chronic suppression. There were four patients with a positive culture who did not receive antibiotics beyond their first week after surgery or until their final culture results became available. In all four patients, the positive culture was only one of four specimens, which grew in broth culture and was a different organism than the initial culture. These results were considered a contaminant.
Patients were followed clinically and radiographically at 6 weeks, 3 months, 1 year, 2 years, 5 years, and 10 years. Any patients who had not returned for their final followup were contacted for the purposes of this report. One patient was lost to followup. All others have a minimum 5-year followup (mean, 11 years; range, 5-20 years) and all living patients have been seen within the last 2 years. Additionally, eight patients died before 5 years followup.
The bacteria were identified for each infection and the information obtained was used to determine if the type of bacteria and its resistance patterns affected the outcome. Bacteria at the time of reinfection were also identified.
Methicillin-resistant Staphylococcus aureus, methicillinresistant Staphylococcus epidermidis, and vancomycin-resistant Enterococcus were defined as resistant pathogens. All other organisms that were cultured were determined to be susceptible. Two patients grew out Pseudomonas aeruginosa, whereas two others grew Serratia marcescens on initial culture; however, all isolated strains were susceptible to many of the common treatments for these Gramnegative organisms. The absence of infection was defined as the absence of symptoms suggestive of infection such as pain at rest, systemic symptoms, or other changes consistent with an infection that are severe enough to encourage the patient to seek medical attention.
Statistical analysis was performed using odds ratios and Fisher's exact test to determine whether there was any association of organism resistance and failure or recurrence of infection after the two-stage reimplantation. The risk of reinfection was determined using cumulative risk methods that considered death as a competing event [4, 14] .
Results

Incidence of Reinfection
Of the 97 joints treated with twostage reimplantation, 12 developed reinfection and eight patients died before 5 years (one of whom was revised before 2 years), leaving 78 of 93 (84%) patients free from infection at a minimum followup of 5 years (range, 5-20 years). In none of the eight patients was the cause of death attributed to their PJI. Five of the infections were recurrent infections caused by the same bacteria that had initially resulted in failure of the implant, whereas seven of these were caused by new or different combinations of bacteria. One of these seven was initially Group C Streptococcus and at the time of failure, Group G Streptococcus was cultured. Another initial infection grew both methicillin-sensitive S aureus (MSSA) and Serratia and at the time of revision, only MSSA was cultured (Table 1 ). In addition to the 12 reinfections, two patients developed mechanical failure at 107 and 118 months after their reimplantation and were treated with surgical revision. Cultures at the time of revision were negative for any bacterial growth. The estimated 10-year cumulative incidence of infection from any cause was 17% (95% confidence interval [CI], 10%-27%), from any infection was 14% (95% CI, 7%-23%), and from the same organism was 5% (95% CI, 1%-11%) (Fig. 1) .
Bacterial Factors
Early infections were more often caused by a resistant organism, whereas late infections involved a different organism or a different combination of organisms than was isolated in the original infection, and none involved resistant organisms (60% [three Of the 97 joints that were reimplanted, 18 (19%) had at least one positive culture from synovial fluid or tissue at the time of reimplantation. Only three of the 12 reinfections had positive cultures at the time of reimplantation, two of which were determined to be contaminants (Table 1) . Seventeen percent of joints with at least one positive culture at the time of reimplantation became reinfected compared with 12% of joints with negative cultures at the time of reimplantation.
Discussion
The results of two-stage hip and knee reimplantation for infection are rarely reported beyond 5-year followup. The projected growth in arthroplasty volume, along with the inevitable increase of PJIs, warrants close investigation about the success of the standard treatment over the long term. We questioned whether joints free from an infection after two-stage reimplantation remained free of infection at longer followup beyond 5 years. Our article has some limitations. First, this is a retrospective review and, as such, is limited by the completeness of the medical records, which may not have data to allow more rigorous scrutiny and analysis. Additionally, the health records in our institution underwent a series of changes from paper charting to electronic health records, perhaps affecting the accuracy of reports produced by International Classification of Diseases, 9 th Revision and Current Procedural Terminology coding. The second weakness of this study is the risk of selection bias common to retrospective studies, but we do not feel it adversely affects our results because we applied consistent indications to all but one patient. The patient in question was a 90-year-old woman with a sensitive pathogen and loose components treated with onestage exchange because of her age and out of concern that she would not tolerate two surgical procedures.
The third limitation to our study is the possibility that patients who appear free from infection may indeed have had an infection present. In other words, we did not proceed with cultures of these joints nor did we apply the Musculoskeletal Infection Society (MSIS) criteria to workup all of these patients at their last followup interval. The effect of this is that our results are a "best case" estimate suggesting that the risk may be even higher with longterm followup such as ours.
A primary purpose of our study was to analyze patients treated with twostage reimplantation for a prosthetic hip or knee infection at longer followup. We were able to either salvage the joint or reimplant 90% of our patients. This is comparable to Toulson et al. [32] , who reimplanted 94% (82 of 87) of their patients, and Berend et al. [3] , who reimplanted 92% (186 of 202) of their patients. We expected some late reinfections, because a risk of infection remains at any length of followup in an implanted joint. Reported reinfection results in the literature range from 6.5% to 24%, and among the listed studies, up to 82% of reinfections occurred within 2 years after successful reimplantation (Table 2) . Those results are similar to our own. We found a higher number of recurrent or new PJIs compared with our previous investigation [36] . Of the 12 additional reinfections, seven were reinfections that occurred 3.5 years or more from the time of their reimplantation. The findings demonstrate the steady attrition over time with failures accumulating even after an extended infection-free interval.
Our second question was if the original bacteria type was associated with a late recurrence. The late infections seen in this study were by new or a different bacterial combination than those identified at the time of the firststage reimplantation. In one joint infected concurrently with Serratia and MSSA, reinfection occurred at 11 years by MSSA only. The problem of a new infection after reimplantation of an infected prosthetic joint is certainly not new. We agree with Zmistowski et al. [39] , who reported two-stage reimplantation is successful in eradicating most of the PJIs and failures are commonly caused by new bacteria. Two-thirds of their patients' recurrent infections were caused by new bacteria and those results are similar to our results with seven of the 12 (58%) identified as new bacteria. Much attention has been given to the influence of the organism, particularly with regard to resistance patterns. In our cohort, three of the five infections resulting from the same methicillinresistant organism identified at débridement ultimately failed within 2 years. This seems to imply difficulty in clearing methicillin-resistant bacteria and the persistence of infection as reported by others [1, 20, 26, 27, 30] . Leung et al. [21] found 21% recurrence of deep methicillin-resistant S aureus or methicillin-resistant S epidermidis infection, whereas Zmistowski et al. The table includes studies documenting the time to failure after reimplantation for a prosthetic hip or knee infection; *there were 13 failures, one of which was treated at an outside institution and time of failure was unknown; †one patient had positive intraoperative cultures and was suppressed for 6 years before undergoing revision.
[39] identified identical resistant organisms at the time of reimplantation and failure in 32% of patients. Cordero-Ampuero et al. [9] prospectively followed 36 patients treated for prosthetic hip infections and reported excellent functional outcomes (Harris hip score 89.5) for infections considered resistant and nonresistant (Harris hip score 86.7) when treated with staged reimplantation. In another study by Cordero-Ampuero et al. [10] , 47 patients treated for prosthetic knee infections were followed; they found a higher number of failures for monomicrobial methicillin-resistant S aureus infections, although functional outcomes were similar regardless of infection type. Our final question was whether the presence of bacteria at the time of reimplantation contributed to failure or reinfection. Interestingly, only one of the 14 patients with what we determined was a positive culture from tissue obtained at the time of reimplantation developed an infection or had persistent PJI. Tan et al. [30] identified 33 patients with one or more positive cultures at reimplantation. Fifteen (45%) joints with positive intraoperative cultures became reinfected compared with 20.9% of those with negative intraoperative cultures. When they controlled for other variables using a multivariate analysis, positive intraoperative cultures were associated with increased risk of infection (odds ratio 2.53). Cabo et al. [6] prospectively interpreted second-stage culture results in 42 prosthetic hip and knee infections and suggested that positive antibiotic spacer cultures combined with positive tissue cultures were indicative of infection in the absence of clinical signs. Other studies have not correlated a positive culture at the time of reimplantation with subsequent late failure [2, 15, 27] . The contrasting results are perhaps explained by small numbers of patients in this and other studies. Alternatively, it is possible that aggressively treating those patients with positive cultures using 6 weeks of antibiotics may have been sufficient to prevent an infection. Recent work by Frank et al. [11] reported the addition of 3 months of oral antibiotics improved the infectionfree survival of their patients after twostage reimplantation, although these results must be considered preliminary with minimum 1-year followup. Finally, the culture result is just one of the criteria to identify an infection. George et al. [12] recommended reassessing the patient's infection at the time of reimplantation using the MSIS criteria as the standard for identifying infection. In their study of 97 patients, MSIS criteria were specific for failure of reimplantation. The authors recommended that both frozen section and MSIS score be used to determine the presence or absence of infection at the time of the reimplantation. If the patient is noted to have an infection, it may be prudent to proceed with another surgical débridement before reimplantation.
In summary, numerous factors compromise the ability to eradicate infections after two-stage reimplantation for a PJI. In our study, early failure was more frequently associated with resistant bacterial infections, whereas late failures involved new pathogens. We did not, however, find a difference in overall failure between resistant and antibiotic-sensitive organisms. Recurrent infections that occur later (> 2 years after reimplantation) are also more frequent than those that occur early after reimplantation, highlighting the importance of educating our patients about the ongoing risk for PJI. Late PJI remains an area where further research into strategies for improvement of long-term success after reimplantation is urgently needed.
